Replies to post #43083 on RespireRx Pharmaceuticals Inc (RSPI)

[jacksonjohn]

Yes, they don't need to do a full NDA. They can submit a 505(b)(2) NDA to the FDA for approval of a new dronabinol label, as opposed to the submission and approval of a full 505(b)(1) NDA.